Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Selecta Biosciences to Participate in Jefferies Virtual Gene Therapy/Editing Summit | ||
By: GlobeNewswire - 20 Oct 2021 | Back to overview list |
|
WATERTOWN, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Virtual Gene Therapy/Editing Summit to be held October 27-28, 2021. Details on the conference can be found below. Jefferies Virtual Gene Therapy/Editing Summit An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com. About Selecta Biosciences, Inc. For Investors: For Media: |
||
|
||
Copyright 2021 GlobeNewswire | Back to overview list |